Spend Friday 14 December learning about and discussing drug-free antibacterial technology for medical applications with Lucideon

Member News published by Cambridge Network

Infection has become one of the toughest problems in the medical world, with bacteria increasingly resistant to drugs. Can infection be controlled and managed using materials and surfaces instead? This question will be explored at a one-day Cambridge Network event next month.

The meeting on Friday 14th December, organised in conjunction with HyMedPoly and Lucideon, will review advances and needs in these technologies from business, clinical and research perspectives.

It will cover aspects including:

  • Clinical need and issues faced by drug-free antibacterial technology
  • Antibacterial materials; synthetic polymers, natural polymers, glasses and ceramics
  • Developing products and novel technologies for medical devices and cosmetic, pharmaceutical and medical applications
  • Networks and support in anti-bacterial technology.

The meeting – which takes place from 9am at The Hauser Forum (The Entrepreneurship Centre, 3 Charles Babbage Road, CB3 0GT) –  is supported in part through HyMedPoly*. This is a four-year Marie Skłodowska-Curie programme project developing new anti-bacterial therapies based on polymers and inorganic materials.

Participants will have an opportunity to view posters on the project and to meet members of the project’s researcher cohort, who will outline results to advance products for medical and personal healthcare. 

This event is being run jointly by Cambridge Network with member, Lucideon, an international, independent materials technology company that applies its materials expertise in ceramics, metals and polymers to a range of sectors including healthcare, construction, ceramics, aerospace and power engineering.

Cost:

Cambridge Network members: There is a charge of £50+VAT per person for attending this one-day event.

Non-members:  There is a charge of £100+VAT per person.

Find out more and sign up here.

*HyMedPoly has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant programme No. 643050.

 

Subscribe to the CW newsletter

This site uses cookies.

We use cookies to help us to improve our site and they enable us to deliver the best possible service and customer experience. By clicking accept or continuing to use this site you are agreeing to our cookies policy. Learn more

Start typing and press enter or the magnifying glass to search